Perfect! I have good data showing analyst activity. Let me write an article focusing on NIKE downgrades, Microsoft upgrades, biotech analyst changes (Apellis, Centessa), defense names getting attention, and the energy sector activity. The data shows some interesting patterns.
NIKE absorbed the heaviest downgrade wave among major stocks. Analysts cut ratings as the $65B apparel giant cratered 31% year to date. The stock hit 20 RSI showing deeply oversold territory. Analyst upside potential held at 48% suggesting Wall Street sees recovery ahead.
MSFT Microsoft grabbed the most upgrades among mega caps. The $2.8T software leader fell 23% in 2026 drawing bargain hunters. Analysts flagged 57% upside potential as AI infrastructure spending accelerated. RSI held at 39 indicating oversold conditions.
Biotech names saw heavy analyst turnover. APLS Apellis led downgrade activity despite surging 61% year to date. The $5.2B drug maker hit 87 RSI signaling extreme overbought levels. Analysts flagged negative 4% upside suggesting profit taking ahead.
CNTA Centessa absorbed multiple downgrades after rocketing 59% in 2026. The biotech held 9.8% analyst upside despite the rally. Ivanhoe Mines saw rating cuts as the $10.7B miner dropped 33% on commodity pressure.
Defense contractors grabbed fresh attention. RCAT Red Cat soared 63% drawing analyst interest. GE General Electric held 26% upside potential. GD General Dynamics showed 13% target room.
HAL Halliburton absorbed downgrades despite jumping 35% as oil spiked past $100. Analysts questioned sustainability showing negative 2% upside potential.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
